Abivax SA Sponsored ADR (ABVX)
(Real Time Quote from BATS)
$70.84 USD
+1.75 (2.53%)
Updated Aug 7, 2025 11:34 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ABVX 70.84 +1.75(2.53%)
Will ABVX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABVX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABVX
Wall Street Analysts See a 360.53% Upside in Abivax SA Sponsored ADR (ABVX): Can the Stock Really Move This High?
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
ABVX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Abivax SA Sponsored ADR (ABVX) Could Surge 427.9%: Read This Before Placing a Bet
Here's Why Abivax SA Sponsored ADR (ABVX) is Poised for a Turnaround After Losing -19.81% in 4 Weeks
Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year?
Other News for ABVX
Abivax (ABVX) Target Price Raised to $112 by Piper Sandler | ABVX Stock News
Abivax price target raised by $42 at Piper Sandler, here's why
Abivax (ABVX) Receives Boosted Price Target from Piper Sandler
Abivax SA (ABVX) Closes $747.5 Million Public Offering | ABVX stock news
Abivax Announces Closing of $747.5 Million Public Offering | ABVX Stock News